Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06191562
Other study ID # STUDY22120108
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 29, 2024
Est. completion date February 2028

Study information

Verified date February 2024
Source University of Pittsburgh
Contact Amber D Shaffer, PhD
Phone 412-692-6874
Email shafferad@upmc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this randomized clinical trial is to compare the results of ear tube placement in two different parts of the ear drum. The ear drum can be divided into four parts (called quadrants). Ear tubes are usually placed in one section of the ear drum, called the anterior-inferior quadrant. However, tubes can also be placed in another section, called the posterior-inferior quadrant. Ear tubes usually fall out of the ear drum on their own. In most patients, the hole in the ear drum where the tube used to be closes on its own. Sometimes (in about 2% of patients), the hole does not close on its own and might need surgery. We want to study ear tube placement in the posterior-inferior quadrant because surgery to repair a hole in the eardrum is easier in this location. For this study, children will receive an ear tube in the usual location (anterior-inferior quadrant) in one ear and the new location (posterior-inferior quadrant) in the other ear. Researchers will determine which ear has the new location using random assignment (like flipping a coin). Researchers will collect information about hearing tests, whether there is ear drainage (otorrhea), if the tube is blocked (occluded), and how the ear drum looks for up to 37 months after tube placement. Participants will answer study questions at 2-12 weeks and 6, 12, 18, 24, 30, and 36 months after surgery. These questions will ask about whether tubes have fallen out of the ear drum, whether there is a hole in the ear drum, whether there has been drainage from the ear or other ear symptoms, and whether there have been any visits to the doctor for ear problems. Researchers will use this information to compare ears with anterior-inferior tube placement and ears with posterior-inferior tube placement to see if there are differences in common complications following tube placement.


Description:

The tympanic membrane can be divided into quadrants: posterior superior, anterior superior, posterior inferior, and anterior inferior. Traditional training dictates that tympanostomy tubes should be placed in the anterior-inferior quadrant, with the thought that this would lead to longer indwelling time in the tympanic membrane, avoidance of damage to the ossicular chain, and prevention of hearing loss due to residual perforation over the round window following tympanostomy tube extrusion. However, more recent work has challenged these assumptions. Notably, there is a 2-16% risk of chronic perforation following tympanostomy tube extrusion, with a proposed annual incidence of more than 40,000 post-tympanostomy tube perforations in the United States each year. While perforations in the posterior tympanic membrane can often be repaired using transcanal approaches, anterior perforations are more likely to require more invasive postauricular or endoaural approaches or canalplasty. To our knowledge, there are no studies reporting outcomes following tympanostomy tube placement in the posterior-inferior quadrant. If this study demonstrates no difference in hearing, tube indwelling time, and sequelae following posterior-inferior placement compared with anterior-inferior, it would allow otolaryngologists greater flexibility to consider patient characteristics such as factors placing them at increased risk for perforation or anatomy of the auditory canal when selecting the section of tympanic membrane in which to place tubes. Upon completion of screening, patients will be randomized using a random number generator in order to have an equal distribution of left and right ears with tympanostomy tubes placed in the anterior and posterior quadrants. Consented patients will receive an ear tube in the usual location (anterior-inferior) in one ear and a new location (posterior-inferior) in the other ear during surgery. Follow-up will include standard-of-care post-operative visits and may be completed at 2-12 weeks and 5-7 months. Clinicians will examine the child's ears and determine whether otorrhea and occlusion are present. During the visit, audiologists may conduct standard of care ear-specific pure tone average, air-bone gap, and sound field audiometry. At these follow-up visits, otolaryngology providers will complete a form describing the status of the tympanic membrane. This will add <1 minute to the visit. Caregivers will also complete a form asking about the status of their child's tympanostomy tubes and any ear problems their child has experienced since surgery. This will take <5 minutes to complete. Results of audiology testing will be collected from the electronic medical record. Additional follow-up will include administration of the caregiver questions via phone, mail, or REDCap email at 12, 18, 24, 30, and 36 months. If the child has other follow-up clinic visits prior to 37 months post-surgery, the provider form will be completed again during these visits. Further research activities will include viewing medical charts of the included subjects.


Recruitment information / eligibility

Status Recruiting
Enrollment 386
Est. completion date February 2028
Est. primary completion date February 2028
Accepts healthy volunteers No
Gender All
Age group 6 Months to 14 Years
Eligibility Inclusion Criteria: 1. Ages 6 months -14 years 2. Bilateral tympanostomy tube placement 3. First tympanostomy tubes placement 4. Indication for tympanostomy tube placement is otitis media Exclusion Criteria: 1. Undergoing tympanostomy tube placement for indication other than otitis media 2. Receiving tubes other than Armstrong grommet. 3. Genetic disorder that impacts the craniofacial structure, immune system, or mucosal secretions such as Downs syndrome, Stickler syndrome, Treacher Collins syndrome, other genetic disorder associated with craniofacial anomalies, Severe Combined Immunodeficiency disorder, Cystic Fibrosis, or Primary Ciliary Dyskinesia 4. Patients with craniofacial abnormalities other than plagiocephaly or submucous cleft palate (SMCP) 5. Caregivers who cannot speak, read, or write in English proficiently 6. Prior or current otologic surgery other than tympanostomy tube placement 7. On systemic corticosteroids at the time of enrollment 8. Immunodeficiency (acquired or congenital) 9. Current retraction, cholesteatoma, or middle ear mass 10. Atresia 11. Sensorineural hearing loss 12. Known ossicular chain anomaly

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Tympanostomy tube
Participants will receive an ear tube in the usual location (anterior-inferior) in one ear and a new location (posterior-inferior) in the other ear during surgery.

Locations

Country Name City State
United States UPMC Children's Hospital of Pittsburgh Pittsburgh Pennsylvania
United States UPMC Children's Hospital of Pittsburgh North Sewickley Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
David Chi, MD

Country where clinical trial is conducted

United States, 

References & Publications (6)

ALBERTI PW. EPITHELIAL MIGRATION ON THE TYMPANIC MEMBRANE. J Laryngol Otol. 1964 Sep;78:808-30. doi: 10.1017/s0022215100062800. No abstract available. — View Citation

Gibb AG, Mackenzie IJ. The extrusion rate of grommets. Otolaryngol Head Neck Surg. 1985 Dec;93(6):695-9. doi: 10.1177/019459988509300601. — View Citation

Kivekas I, Poe D. Is there an optimal location for tympanostomy tube placement? Laryngoscope. 2015 Jul;125(7):1513-4. doi: 10.1002/lary.25127. Epub 2015 Jan 13. No abstract available. — View Citation

Mehta RP, Rosowski JJ, Voss SE, O'Neil E, Merchant SN. Determinants of hearing loss in perforations of the tympanic membrane. Otol Neurotol. 2006 Feb;27(2):136-43. doi: 10.1097/01.mao.0000176177.17636.53. — View Citation

O'Donoghue GM. The kinetics of epithelial cells in relation to ventilating tubes. Acta Otolaryngol. 1984 Jul-Aug;98(1-2):105-9. doi: 10.3109/00016488409107541. — View Citation

Stinson WD. Reparative processes in the membrana tympani: some interested manifestations. Arch Otolaryngol. 1936; 24(5): 600-605. doi:10.1001/archotol.1936.00640050613006.

Outcome

Type Measure Description Time frame Safety issue
Other Parent-reported otorrhea at 12 months Percentage of ears with ear drainage most days (67-100%), many days (33-67%), some days (1-33%) or no days (0) 12 months±30 days following tympanostomy tube placement
Other Parent-reported otorrhea at 18 months Percentage of ears with ear drainage most days (67-100%), many days (33-67%), some days (1-33%) or no days (0) 18 months±30 days following tympanostomy tube placement
Other Parent-reported otorrhea at 24 months Percentage of ears with ear drainage most days (67-100%), many days (33-67%), some days (1-33%) or no days (0) 24 months±30 days following tympanostomy tube placement
Other Parent-reported otorrhea at 30 months Percentage of ears with ear drainage most days (67-100%), many days (33-67%), some days (1-33%) or no days (0) 30 months±30 days following tympanostomy tube placement
Other Parent-reported otorrhea at 36 months Percentage of ears with ear drainage most days (67-100%), many days (33-67%), some days (1-33%) or no days (0) 36 months±30 days following tympanostomy tube placement
Other Parent-reported blockage of tube lumen at 2-12 weeks Percentage of ears clogged/blocked 2-12 weeks following tympanostomy tube placement
Other Parent-reported blockage of tube lumen at 6 months Percentage of ears clogged/blocked 6 months±30 days following tympanostomy tube placement
Other Parent-reported blockage of tube lumen at 12 months Percentage of ears clogged/blocked 12 months±30 days following tympanostomy tube placement
Other Parent-reported blockage of tube lumen at 18 months Percentage of ears clogged/blocked 18 months±30 days following tympanostomy tube placement
Other Parent-reported blockage of tube lumen at 24 months Percentage of ears clogged/blocked 24 months±30 days following tympanostomy tube placement
Other Parent-reported blockage of tube lumen at 30 months Percentage of ears clogged/blocked 30 months±30 days following tympanostomy tube placement
Other Parent-reported blockage of tube lumen at 36 months Percentage of ears clogged/blocked 36 months±30 days following tympanostomy tube placement
Other Provider-observed otorrhea at 2-12 weeks Percentage of ears with otorrhea observed by provider 2-12 weeks following tympanostomy tube placement
Other Provider-observed otorrhea at 6 months Percentage of ears with otorrhea observed by provider 6 months±30 days following tympanostomy tube placement
Other Provider-observed otorrhea at 12 months Percentage of ears with otorrhea observed by provider 12 months±30 days following tympanostomy tube placement
Other Provider-observed otorrhea at 18 months Percentage of ears with otorrhea observed by provider 18 months±30 days following tympanostomy tube placement
Other Provider-observed otorrhea at 24 months Percentage of ears with otorrhea observed by provider 24 months±30 days following tympanostomy tube placement
Other Provider-observed otorrhea at 30 months Percentage of ears with otorrhea observed by provider 30 months±30 days following tympanostomy tube placement
Other Provider-observed otorrhea at 36 months Percentage of ears with otorrhea observed by provider 36 months±30 days following tympanostomy tube placement
Other Provider-observed tube occlusion at 12 months Percentage of ears with tubes occluded 12 months±30 days following tympanostomy tube placement
Other Provider-observed tube occlusion at 18 months Percentage of ears with tubes occluded 18 months±30 days following tympanostomy tube placement
Other Provider-observed tube occlusion at 24 months Percentage of ears with tubes occluded 24 months±30 days following tympanostomy tube placement
Other Provider-observed tube occlusion at 30 months Percentage of ears with tubes occluded 30 months±30 days following tympanostomy tube placement
Other Provider-observed tube occlusion at 36 months Percentage of ears with tubes occluded 36 months±30 days following tympanostomy tube placement
Other Provider-observed tympanostomy tubes in place and patent at 12 months Percentage of ears with tympanostomy tubes in place and patent 12 months±30 days following tympanostomy tube placement
Other Provider-observed tympanostomy tubes in place and patent at 18 months Percentage of ears with tympanostomy tubes in place and patent 18 months±30 days following tympanostomy tube placement
Other Provider-observed tympanostomy tubes in place and patent at 24 months Percentage of ears with tympanostomy tubes in place and patent 24 months±30 days following tympanostomy tube placement
Other Provider-observed tympanostomy tubes in place and patent at 30 months Percentage of ears with tympanostomy tubes in place and patent 30 months±30 days following tympanostomy tube placement
Other Provider-observed tympanostomy tubes in place and patent at 36 months Percentage of ears with tympanostomy tubes in place and patent 36 months±30 days following tympanostomy tube placement
Other Ability to see through lumen and assess tube patency at 12 months Percentage of ears in which the otolaryngology provider is able to see through lumen and assess tube patency 12 months±30 days following tympanostomy tube placement
Other Ability to see through lumen and assess tube patency at 18 months Percentage of ears in which the otolaryngology provider is able to see through lumen and assess tube patency 18 months±30 days following tympanostomy tube placement
Other Ability to see through lumen and assess tube patency at 24 months Percentage of ears in which the otolaryngology provider is able to see through lumen and assess tube patency 24 months±30 days following tympanostomy tube placement
Other Ability to see through lumen and assess tube patency at 30 months Percentage of ears in which the otolaryngology provider is able to see through lumen and assess tube patency 30 months±30 days following tympanostomy tube placement
Other Ability to see through lumen and assess tube patency at 36 months Percentage of ears in which the otolaryngology provider is able to see through lumen and assess tube patency 36 months±30 days following tympanostomy tube placement
Other Ear-specific pure tone average Highest (worst) pure tone average of 500 Hz, 1000 Hz, 2000 Hz, and 3000 Hz in decibels Within 36 months +/- 30 days following tympanostomy tube placement
Other Ear-specific speech-response threshold Highest (worst) speech-response threshold in decibels 36 months±30 days following tympanostomy tube placement
Other Ear-specific speech-awareness threshold Highest (worst) speech-awareness threshold in decibels Within 36 months +/- 30 days following tympanostomy tube placement
Primary Perforation Percentage of ears with persistent (>3 month) perforation of the tympanic membrane Within 36 months +/- 30 days following tympanostomy tube placement
Secondary Parent-reported otorrhea at 2-12 weeks Percentage of ears with ear drainage most days (67-100%), many days (33-67%), some days (1-33%) or no days (0) 2-12 weeks following tympanostomy tube placement
Secondary Parent-reported otorrhea at 6 months Percentage of ears with ear drainage most days (67-100%), many days (33-67%), some days (1-33%) or no days (0) 6 months±30 days following tympanostomy tube placement
Secondary Provider-observed tube occlusion at 2-12 weeks Percentage of ears with tubes occluded 2-12 weeks following tympanostomy tube placement
Secondary Provider-observed tube occlusion at 6 months Percentage of ears with tubes occluded 6 months±30 days following tympanostomy tube placement
Secondary Provider-observed tympanostomy tubes in place and patent at 2-12 weeks Percentage of ears with tympanostomy tubes in place and patent 2-12 weeks following tympanostomy tube placement
Secondary Provider-observed tympanostomy tubes in place and patent at 6 months Percentage of ears with tympanostomy tubes in place and patent 6 months±30 days following tympanostomy tube placement
Secondary Retained tubes requiring surgical intervention Percentage of ears requiring surgical tympanostomy tube removal Within 36 months +/- 30 days following tympanostomy tube placement
Secondary Perforation requiring surgical intervention Percentage of ears with surgical repair of perforation Within 36 months +/- 30 days following tympanostomy tube placement
Secondary Atrophy or retraction at tube site Percentage of ears with atrophy or retraction at tube site Within 36 months +/- 30 days following tympanostomy tube placement
Secondary Cholesteatoma Percentage of ears with cholesteatoma Within 36 months +/- 30 days following tympanostomy tube placement
Secondary Hearing loss Percentage of ears with pure tone average >20 dB or absent otoacoustic emissions Within 36 months +/- 30 days following tympanostomy tube placement
Secondary Tube indwelling time before extrusion Months from tympanostomy tube placement to extrusion estimated from parent-report and provider observations Within 36 months +/- 30 days following tympanostomy tube placement
Secondary Ability to see through lumen and assess tube patency at 2-12 weeks Percentage of ears in which the otolaryngology provider is able to see through lumen and assess tube patency 2-12 weeks following tympanostomy tube placement
Secondary Ability to see through lumen and assess tube patency at 6 months Percentage of ears in which the otolaryngology provider is able to see through lumen and assess tube patency 6 months±30 days following tympanostomy tube placement
See also
  Status Clinical Trial Phase
Recruiting NCT05348291 - Effect of Ventilation Tubes in Otitis-prone Children N/A
Active, not recruiting NCT00809601 - Study of Different Kinds of Ear Tubes N/A
Completed NCT01263210 - Pneumococcal Vaccination of Otitis-prone Children N/A
Withdrawn NCT03534219 - Efficacy of the EarPopper Device in Children With Recurrent Otitis Media N/A
Completed NCT00941993 - Anesthetic Effect of Lidocaine/Epinephrine Solution Delivered Via Iontophoresis to External Auditory Apparatus N/A